Simon Baumgart

Critic
DISC Type : C

Associate Director Bioinformatics at Asgard Therapeutics

Copenhagen, Capital Region of Denmark, Denmark

Overview

Simon is a leader in pharmaceutical R&D at Asgard Therapeutics, with over eight years of experience specializing in translational medicine and data science. His background includes impactful roles at Novo Nordisk and Bayer. A colleague described him as an inspirational combination of deep scientific knowledge, passion, and leadership.

He is passionate about the intersection of science and technology, reflecting on how diverse data modalities generate great findings. He has also expressed interest in finding online platforms that can better facilitate high-level scientific discourse, recently trying BlueSky after leaving X (formerly Twitter).

Unique Fact: As a Product Owner at Novo Nordisk, he drove an 80% improvement in high-throughput RNAseq analysis turnaround time.

Personality Overview

Precise

Negotiator

ROI Driven

They are quite likely to negotiate on pricing or other key terms.  They choose to analyze logically and value facts to emotions. They don’t appreciate bells and whistles unless backed by data.

Topics They Care About

Translational Medicine
His career focuses on bridging complex scientific data with R&D strategy to drive high-impact pharmaceutical projects.
Data & AI Strategy
He has led teams defining data strategies and leveraging data for algorithmic decision-making to create high-value digital tools in pharma.
Drug Development
His work has directly contributed to over 15 pipeline entries and the identification of new targets for cardiometabolic diseases and prostate cancer.

Media Appearances

Simon has no verified media appearances

Work History

2-2026
Associate Director Bioinformatics at Asgard Therapeutics
1-2025
External Innovation Lead (Short Time Assignment) at Novo Nordisk
12-2023 - 10-2025
Scientific Product Owner at Novo Nordisk
1-2021 - 12-2023
Computational Biologist at Novo Nordisk
2-2019 - 11-2019
Research Scientist at Bayer Pharmaceuticals

Education

1-2023 - 12-2025
Executive MBA from Vlerick Business School
2012 - 2016
Doctor of Philosophy - PhD from The University of Göttingen

More Information

Social Presence :

Prographics :

Exp : 12 Location : Copenhagen, Capital Region of Denmark, Denmark Job Level : Mid-senior Designation : Associate Director Bioinformatics at Asgard Therapeutics
URL has been copied!

Insights For Selling To Simon

During A Call Or A Meeting

DO's

  • Be ready for penetrating questions and critical examination of your pitch
  • Be formal and objective, they will appreciate it more
  • Leverage facts and figures wherever possible; use percentages, numbers etc.

DONT's

  • Do not use very emotional or colorful language
  • Make extra effort to not seem pushy or confrontational
  • Don’t try to give too many examples of other users, they like to make their own decisions

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Simon is

  • Proven ROI, pricing and objective proof points are the factors that sway their decision.
  • Will you ever get a clear answer from Simon

  • They are comfortable saying no if they are convinced that it is the correct decision.

Insights For Deal Planning

    How fast (or slow) will Simon move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Simon take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Simon

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.